Immunoglobulin G Lambda Heavy And Light Chain Combined
PCO · Class II — Moderate Risk (510(k) clearance required) · Immunology · 21 CFR 866.5510
Classification
FDA Product Code
PCO
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.5510
Review panel
IM
Medical specialty
Immunology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
Y
Definition
Intended for the in-vitro quantification of IgG lambda concentration in human serum. The result is to be used with previously diagnosed IgG multiple myeloma, in conjunction with other clinical and laboratory findings.